nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A4—Tiotropium—chronic obstructive pulmonary disease	0.305	0.421	CbGbCtD
Procainamide—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.172	0.238	CbGbCtD
Procainamide—CHRM2—Tiotropium—chronic obstructive pulmonary disease	0.113	0.156	CbGbCtD
Procainamide—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0462	0.0639	CbGbCtD
Procainamide—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0462	0.0639	CbGbCtD
Procainamide—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0412	0.0569	CbGbCtD
Procainamide—Atrial tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.0289	0.147	CcSEcCtD
Procainamide—BCHE—diaphragm—chronic obstructive pulmonary disease	0.00883	0.219	CbGeAlD
Procainamide—Cardiac fibrillation—Salbutamol—chronic obstructive pulmonary disease	0.00663	0.0337	CcSEcCtD
Procainamide—Electrocardiogram change—Salbutamol—chronic obstructive pulmonary disease	0.00606	0.0307	CcSEcCtD
Procainamide—Supraventricular tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00368	0.0187	CcSEcCtD
Procainamide—Supraventricular tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00347	0.0176	CcSEcCtD
Procainamide—Supraventricular tachycardia—Formoterol—chronic obstructive pulmonary disease	0.0028	0.0142	CcSEcCtD
Procainamide—Supraventricular tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.0028	0.0142	CcSEcCtD
Procainamide—Atrial fibrillation—Roflumilast—chronic obstructive pulmonary disease	0.00277	0.014	CcSEcCtD
Procainamide—Supraventricular tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00264	0.0134	CcSEcCtD
Procainamide—DNMT1—respiratory system—chronic obstructive pulmonary disease	0.00252	0.0627	CbGeAlD
Procainamide—Ventricular tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.00227	0.0115	CcSEcCtD
Procainamide—DNMT1—connective tissue—chronic obstructive pulmonary disease	0.00222	0.0552	CbGeAlD
Procainamide—Lightheadedness—Aminophylline—chronic obstructive pulmonary disease	0.00216	0.0109	CcSEcCtD
Procainamide—DNMT1—bronchus—chronic obstructive pulmonary disease	0.00208	0.0516	CbGeAlD
Procainamide—Depression—Roflumilast—chronic obstructive pulmonary disease	0.00202	0.0102	CcSEcCtD
Procainamide—DNMT1—trachea—chronic obstructive pulmonary disease	0.00187	0.0463	CbGeAlD
Procainamide—Atrial fibrillation—Aminophylline—chronic obstructive pulmonary disease	0.00185	0.00937	CcSEcCtD
Procainamide—Vasculitis—Montelukast—chronic obstructive pulmonary disease	0.00184	0.00934	CcSEcCtD
Procainamide—SCN7A—lung—chronic obstructive pulmonary disease	0.00174	0.0433	CbGeAlD
Procainamide—Arthritis—Tiotropium—chronic obstructive pulmonary disease	0.0017	0.00861	CcSEcCtD
Procainamide—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.00168	0.00855	CcSEcCtD
Procainamide—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.0016	0.00811	CcSEcCtD
Procainamide—SLC22A4—respiratory system—chronic obstructive pulmonary disease	0.00156	0.0389	CbGeAlD
Procainamide—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00786	CcSEcCtD
Procainamide—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.00155	0.00785	CcSEcCtD
Procainamide—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.00147	0.00744	CcSEcCtD
Procainamide—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.00144	0.00732	CcSEcCtD
Procainamide—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00142	0.00723	CcSEcCtD
Procainamide—Atrial fibrillation—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00713	CcSEcCtD
Procainamide—Atrial fibrillation—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00713	CcSEcCtD
Procainamide—Hepatomegaly—Prednisolone—chronic obstructive pulmonary disease	0.0014	0.00712	CcSEcCtD
Procainamide—Moclobemide—CYP1A2—chronic obstructive pulmonary disease	0.0014	0.364	CrCbGaD
Procainamide—Arthritis—Arformoterol—chronic obstructive pulmonary disease	0.00137	0.00695	CcSEcCtD
Procainamide—Arthritis—Formoterol—chronic obstructive pulmonary disease	0.00137	0.00695	CcSEcCtD
Procainamide—SCN9A—lung—chronic obstructive pulmonary disease	0.00137	0.034	CbGeAlD
Procainamide—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.00134	0.00682	CcSEcCtD
Procainamide—DNMT1—lung—chronic obstructive pulmonary disease	0.00134	0.0333	CbGeAlD
Procainamide—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00133	0.00674	CcSEcCtD
Procainamide—Atrial fibrillation—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00673	CcSEcCtD
Procainamide—Lidocaine—EGFR—chronic obstructive pulmonary disease	0.0013	0.338	CrCbGaD
Procainamide—SLC22A4—bronchus—chronic obstructive pulmonary disease	0.00129	0.032	CbGeAlD
Procainamide—SLC22A3—connective tissue—chronic obstructive pulmonary disease	0.00125	0.0311	CbGeAlD
Procainamide—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.00125	0.00634	CcSEcCtD
Procainamide—SCN1A—lung—chronic obstructive pulmonary disease	0.00118	0.0292	CbGeAlD
Procainamide—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.00596	CcSEcCtD
Procainamide—SLC22A4—trachea—chronic obstructive pulmonary disease	0.00116	0.0287	CbGeAlD
Procainamide—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00583	CcSEcCtD
Procainamide—SLC22A3—smooth muscle tissue—chronic obstructive pulmonary disease	0.00115	0.0285	CbGeAlD
Procainamide—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.0057	CcSEcCtD
Procainamide—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00112	0.00569	CcSEcCtD
Procainamide—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00566	CcSEcCtD
Procainamide—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00106	0.00539	CcSEcCtD
Procainamide—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.00535	CcSEcCtD
Procainamide—SCN10A—lung—chronic obstructive pulmonary disease	0.00104	0.0258	CbGeAlD
Procainamide—SLC22A5—respiratory system—chronic obstructive pulmonary disease	0.00103	0.0257	CbGeAlD
Procainamide—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.0052	CcSEcCtD
Procainamide—Hepatomegaly—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00517	CcSEcCtD
Procainamide—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00102	0.00517	CcSEcCtD
Procainamide—Vasculitis—Prednisolone—chronic obstructive pulmonary disease	0.00102	0.00516	CcSEcCtD
Procainamide—BCHE—respiratory system—chronic obstructive pulmonary disease	0.00101	0.025	CbGeAlD
Procainamide—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00095	0.00482	CcSEcCtD
Procainamide—SCN3A—lung—chronic obstructive pulmonary disease	0.000948	0.0236	CbGeAlD
Procainamide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.000925	0.00469	CcSEcCtD
Procainamide—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.000913	0.00463	CcSEcCtD
Procainamide—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000908	0.00461	CcSEcCtD
Procainamide—Hallucination—Montelukast—chronic obstructive pulmonary disease	0.000897	0.00455	CcSEcCtD
Procainamide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000882	0.00448	CcSEcCtD
Procainamide—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.000855	0.00434	CcSEcCtD
Procainamide—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.000855	0.00434	CcSEcCtD
Procainamide—DNMT1—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.000853	0.228	CbGdCrCtD
Procainamide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000852	0.00433	CcSEcCtD
Procainamide—SLC22A5—bronchus—chronic obstructive pulmonary disease	0.000852	0.0212	CbGeAlD
Procainamide—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000846	0.00429	CcSEcCtD
Procainamide—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000846	0.00429	CcSEcCtD
Procainamide—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000846	0.00429	CcSEcCtD
Procainamide—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.000837	0.00425	CcSEcCtD
Procainamide—DNMT1—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.000833	0.222	CbGdCrCtD
Procainamide—SLC22A4—lung—chronic obstructive pulmonary disease	0.00083	0.0206	CbGeAlD
Procainamide—BCHE—bronchus—chronic obstructive pulmonary disease	0.000829	0.0206	CbGeAlD
Procainamide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00082	0.00416	CcSEcCtD
Procainamide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000819	0.00416	CcSEcCtD
Procainamide—BCHE—smooth muscle tissue—chronic obstructive pulmonary disease	0.000811	0.0202	CbGeAlD
Procainamide—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.000807	0.0041	CcSEcCtD
Procainamide—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000807	0.0041	CcSEcCtD
Procainamide—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000803	0.00408	CcSEcCtD
Procainamide—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000797	0.00405	CcSEcCtD
Procainamide—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000785	0.00398	CcSEcCtD
Procainamide—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000785	0.00398	CcSEcCtD
Procainamide—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00078	0.00396	CcSEcCtD
Procainamide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000766	0.00389	CcSEcCtD
Procainamide—SLC22A5—trachea—chronic obstructive pulmonary disease	0.000765	0.019	CbGeAlD
Procainamide—SLC22A3—lung—chronic obstructive pulmonary disease	0.000756	0.0188	CbGeAlD
Procainamide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000747	0.00379	CcSEcCtD
Procainamide—BCHE—trachea—chronic obstructive pulmonary disease	0.000745	0.0185	CbGeAlD
Procainamide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000744	0.00377	CcSEcCtD
Procainamide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000744	0.00377	CcSEcCtD
Procainamide—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000741	0.00376	CcSEcCtD
Procainamide—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.000739	0.00375	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000739	0.00375	CcSEcCtD
Procainamide—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000732	0.00372	CcSEcCtD
Procainamide—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000732	0.00372	CcSEcCtD
Procainamide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000723	0.00367	CcSEcCtD
Procainamide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000723	0.00367	CcSEcCtD
Procainamide—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000717	0.00364	CcSEcCtD
Procainamide—Lidocaine—CYP1A2—chronic obstructive pulmonary disease	0.000717	0.186	CrCbGaD
Procainamide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000703	0.00357	CcSEcCtD
Procainamide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000702	0.00356	CcSEcCtD
Procainamide—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000692	0.00351	CcSEcCtD
Procainamide—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.000685	0.00348	CcSEcCtD
Procainamide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000683	0.00347	CcSEcCtD
Procainamide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000683	0.00346	CcSEcCtD
Procainamide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000682	0.00346	CcSEcCtD
Procainamide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000682	0.00346	CcSEcCtD
Procainamide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000682	0.00346	CcSEcCtD
Procainamide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000682	0.00346	CcSEcCtD
Procainamide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00068	0.00345	CcSEcCtD
Procainamide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000679	0.00345	CcSEcCtD
Procainamide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000679	0.00345	CcSEcCtD
Procainamide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000674	0.00342	CcSEcCtD
Procainamide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000674	0.00342	CcSEcCtD
Procainamide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000668	0.00339	CcSEcCtD
Procainamide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000668	0.00339	CcSEcCtD
Procainamide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000663	0.00336	CcSEcCtD
Procainamide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000644	0.00327	CcSEcCtD
Procainamide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000644	0.00327	CcSEcCtD
Procainamide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000644	0.00327	CcSEcCtD
Procainamide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000641	0.00325	CcSEcCtD
Procainamide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000637	0.00323	CcSEcCtD
Procainamide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000633	0.00321	CcSEcCtD
Procainamide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000627	0.00318	CcSEcCtD
Procainamide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000611	0.0031	CcSEcCtD
Procainamide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000611	0.0031	CcSEcCtD
Procainamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000608	0.00309	CcSEcCtD
Procainamide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000608	0.00308	CcSEcCtD
Procainamide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000597	0.00303	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000596	0.00302	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000596	0.00302	CcSEcCtD
Procainamide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000589	0.00299	CcSEcCtD
Procainamide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000588	0.00298	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000584	0.00296	CcSEcCtD
Procainamide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000577	0.00293	CcSEcCtD
Procainamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000573	0.00291	CcSEcCtD
Procainamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000568	0.00288	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000563	0.00286	CcSEcCtD
Procainamide—SLC22A5—lung—chronic obstructive pulmonary disease	0.000549	0.0137	CbGeAlD
Procainamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000547	0.00277	CcSEcCtD
Procainamide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000539	0.00274	CcSEcCtD
Procainamide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000539	0.00274	CcSEcCtD
Procainamide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000537	0.00273	CcSEcCtD
Procainamide—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000537	0.00272	CcSEcCtD
Procainamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000536	0.00272	CcSEcCtD
Procainamide—BCHE—lung—chronic obstructive pulmonary disease	0.000535	0.0133	CbGeAlD
Procainamide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000535	0.00271	CcSEcCtD
Procainamide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000535	0.00271	CcSEcCtD
Procainamide—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000535	0.00271	CcSEcCtD
Procainamide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000524	0.00266	CcSEcCtD
Procainamide—DNMT1—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.000522	0.139	CbGdCrCtD
Procainamide—DNMT1—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.000522	0.139	CbGdCrCtD
Procainamide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00052	0.00264	CcSEcCtD
Procainamide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00052	0.00264	CcSEcCtD
Procainamide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000517	0.00262	CcSEcCtD
Procainamide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000517	0.00262	CcSEcCtD
Procainamide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000517	0.00262	CcSEcCtD
Procainamide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000517	0.00262	CcSEcCtD
Procainamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000515	0.00262	CcSEcCtD
Procainamide—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000512	0.0026	CcSEcCtD
Procainamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000511	0.00259	CcSEcCtD
Procainamide—DNMT1—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00051	0.136	CbGdCrCtD
Procainamide—DNMT1—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00051	0.136	CbGdCrCtD
Procainamide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000509	0.00258	CcSEcCtD
Procainamide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000509	0.00258	CcSEcCtD
Procainamide—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000508	0.00258	CcSEcCtD
Procainamide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000507	0.00257	CcSEcCtD
Procainamide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000507	0.00257	CcSEcCtD
Procainamide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000505	0.00256	CcSEcCtD
Procainamide—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000498	0.00253	CcSEcCtD
Procainamide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000491	0.00249	CcSEcCtD
Procainamide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000488	0.00248	CcSEcCtD
Procainamide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000488	0.00248	CcSEcCtD
Procainamide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000482	0.00245	CcSEcCtD
Procainamide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000482	0.00245	CcSEcCtD
Procainamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000481	0.00244	CcSEcCtD
Procainamide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000472	0.0024	CcSEcCtD
Procainamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000469	0.00238	CcSEcCtD
Procainamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000469	0.00238	CcSEcCtD
Procainamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000463	0.00235	CcSEcCtD
Procainamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000463	0.00235	CcSEcCtD
Procainamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00046	0.00233	CcSEcCtD
Procainamide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000455	0.00231	CcSEcCtD
Procainamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000453	0.0023	CcSEcCtD
Procainamide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000448	0.00227	CcSEcCtD
Procainamide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000448	0.00227	CcSEcCtD
Procainamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000443	0.00225	CcSEcCtD
Procainamide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000438	0.00223	CcSEcCtD
Procainamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000437	0.00222	CcSEcCtD
Procainamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000433	0.0022	CcSEcCtD
Procainamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000433	0.0022	CcSEcCtD
Procainamide—Probenecid—ALB—chronic obstructive pulmonary disease	0.000431	0.112	CrCbGaD
Procainamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000424	0.00215	CcSEcCtD
Procainamide—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000423	0.00215	CcSEcCtD
Procainamide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.00214	CcSEcCtD
Procainamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00211	CcSEcCtD
Procainamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00211	CcSEcCtD
Procainamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.00207	CcSEcCtD
Procainamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00207	CcSEcCtD
Procainamide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000403	0.00204	CcSEcCtD
Procainamide—Depression—Prednisone—chronic obstructive pulmonary disease	0.000402	0.00204	CcSEcCtD
Procainamide—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000397	0.00201	CcSEcCtD
Procainamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.00199	CcSEcCtD
Procainamide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000391	0.00199	CcSEcCtD
Procainamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000389	0.00197	CcSEcCtD
Procainamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000389	0.00197	CcSEcCtD
Procainamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000381	0.00193	CcSEcCtD
Procainamide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000376	0.00191	CcSEcCtD
Procainamide—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000369	0.00187	CcSEcCtD
Procainamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.00186	CcSEcCtD
Procainamide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000365	0.00185	CcSEcCtD
Procainamide—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000361	0.00183	CcSEcCtD
Procainamide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000349	0.00177	CcSEcCtD
Procainamide—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000336	0.00171	CcSEcCtD
Procainamide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000293	0.00149	CcSEcCtD
Procainamide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000292	0.00148	CcSEcCtD
Procainamide—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000288	0.00146	CcSEcCtD
Procainamide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000284	0.00144	CcSEcCtD
Procainamide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000281	0.00143	CcSEcCtD
Procainamide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000273	0.00139	CcSEcCtD
Procainamide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00136	CcSEcCtD
Procainamide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000269	0.00136	CcSEcCtD
Procainamide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000265	0.00135	CcSEcCtD
Procainamide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000261	0.00132	CcSEcCtD
Procainamide—Shock—Prednisone—chronic obstructive pulmonary disease	0.000253	0.00129	CcSEcCtD
Procainamide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000245	0.00125	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000235	0.00119	CcSEcCtD
Procainamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000234	0.00119	CcSEcCtD
Procainamide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000224	0.00114	CcSEcCtD
Procainamide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000212	0.00108	CcSEcCtD
Procainamide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000211	0.00107	CcSEcCtD
Procainamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00021	0.00107	CcSEcCtD
Procainamide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000205	0.00104	CcSEcCtD
Procainamide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00103	CcSEcCtD
Procainamide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000204	0.00103	CcSEcCtD
Procainamide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000963	CcSEcCtD
Procainamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000937	CcSEcCtD
Procainamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000924	CcSEcCtD
Procainamide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000894	CcSEcCtD
Procainamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00017	0.000864	CcSEcCtD
Procainamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000164	0.000831	CcSEcCtD
Procainamide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000776	CcSEcCtD
Procainamide—SCN7A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	4.76e-05	0.00151	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	4.72e-05	0.00149	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.7e-05	0.00149	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	4.69e-05	0.00148	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	4.68e-05	0.00148	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.63e-05	0.00147	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—IL6—chronic obstructive pulmonary disease	4.57e-05	0.00145	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.56e-05	0.00145	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—TNF—chronic obstructive pulmonary disease	4.54e-05	0.00144	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	4.5e-05	0.00142	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	4.5e-05	0.00142	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—EGFR—chronic obstructive pulmonary disease	4.4e-05	0.00139	CbGpPWpGaD
Procainamide—ACHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.37e-05	0.00138	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	4.33e-05	0.00137	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	4.33e-05	0.00137	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	4.33e-05	0.00137	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	4.33e-05	0.00137	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	4.32e-05	0.00137	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.3e-05	0.00136	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.29e-05	0.00136	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GC—chronic obstructive pulmonary disease	4.25e-05	0.00135	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	4.25e-05	0.00134	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—EGFR—chronic obstructive pulmonary disease	4.21e-05	0.00133	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	4.19e-05	0.00133	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—IL6—chronic obstructive pulmonary disease	4.18e-05	0.00132	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	4.12e-05	0.0013	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.1e-05	0.0013	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—EGFR—chronic obstructive pulmonary disease	4.05e-05	0.00128	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—EGFR—chronic obstructive pulmonary disease	4.05e-05	0.00128	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—TNF—chronic obstructive pulmonary disease	4.04e-05	0.00128	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—LEP—chronic obstructive pulmonary disease	4.03e-05	0.00128	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.96e-05	0.00125	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.95e-05	0.00125	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.9e-05	0.00124	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—EGFR—chronic obstructive pulmonary disease	3.9e-05	0.00124	CbGpPWpGaD
Procainamide—BCHE—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.9e-05	0.00123	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.89e-05	0.00123	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.88e-05	0.00123	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	3.86e-05	0.00122	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.86e-05	0.00122	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.81e-05	0.00121	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	3.8e-05	0.0012	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GC—chronic obstructive pulmonary disease	3.79e-05	0.0012	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	3.78e-05	0.0012	CbGpPWpGaD
Procainamide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	3.76e-05	0.00119	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.72e-05	0.00118	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—TNF—chronic obstructive pulmonary disease	3.7e-05	0.00117	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	3.68e-05	0.00117	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—IL6—chronic obstructive pulmonary disease	3.66e-05	0.00116	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.57e-05	0.00113	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.57e-05	0.00113	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.55e-05	0.00112	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.53e-05	0.00112	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.52e-05	0.00112	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	3.51e-05	0.00111	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.5e-05	0.00111	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.49e-05	0.00111	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.48e-05	0.0011	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	3.47e-05	0.0011	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.44e-05	0.00109	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	3.44e-05	0.00109	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.43e-05	0.00109	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	3.41e-05	0.00108	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—MMP9—chronic obstructive pulmonary disease	3.39e-05	0.00107	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—ACE—chronic obstructive pulmonary disease	3.39e-05	0.00107	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GC—chronic obstructive pulmonary disease	3.39e-05	0.00107	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—IL6—chronic obstructive pulmonary disease	3.38e-05	0.00107	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.36e-05	0.00106	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.34e-05	0.00106	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	3.33e-05	0.00106	CbGpPWpGaD
Procainamide—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.32e-05	0.00105	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—IL6—chronic obstructive pulmonary disease	3.26e-05	0.00103	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.24e-05	0.00103	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.24e-05	0.00103	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—IL6—chronic obstructive pulmonary disease	3.24e-05	0.00102	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	3.22e-05	0.00102	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.21e-05	0.00102	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.21e-05	0.00102	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.2e-05	0.00101	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.19e-05	0.00101	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	3.18e-05	0.00101	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.18e-05	0.00101	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GC—chronic obstructive pulmonary disease	3.16e-05	0.000999	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.15e-05	0.000997	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.15e-05	0.000997	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3.14e-05	0.000995	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	3.14e-05	0.000993	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—IL6—chronic obstructive pulmonary disease	3.11e-05	0.000985	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—IL6—chronic obstructive pulmonary disease	3.11e-05	0.000985	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.09e-05	0.00098	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	3.09e-05	0.00098	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	3.06e-05	0.000971	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—VEGFA—chronic obstructive pulmonary disease	3.05e-05	0.000965	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—PLAUR—chronic obstructive pulmonary disease	3.05e-05	0.000964	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	3.03e-05	0.000958	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	3e-05	0.000952	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—IL6—chronic obstructive pulmonary disease	3e-05	0.000949	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—IL6—chronic obstructive pulmonary disease	3e-05	0.000949	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.99e-05	0.000947	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.99e-05	0.000945	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.98e-05	0.000945	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.97e-05	0.000942	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.95e-05	0.000934	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.94e-05	0.000932	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.94e-05	0.000932	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.93e-05	0.000929	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GCLC—chronic obstructive pulmonary disease	2.92e-05	0.000923	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.89e-05	0.000914	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.89e-05	0.000914	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.86e-05	0.000906	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.84e-05	0.000899	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2.84e-05	0.000899	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	2.83e-05	0.000895	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	2.82e-05	0.000893	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.81e-05	0.000889	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	2.8e-05	0.000888	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.78e-05	0.000882	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	2.78e-05	0.000882	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.75e-05	0.000871	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.75e-05	0.000871	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—EGFR—chronic obstructive pulmonary disease	2.74e-05	0.000869	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.7e-05	0.000857	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.7e-05	0.000855	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.67e-05	0.000845	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CTGF—chronic obstructive pulmonary disease	2.66e-05	0.000842	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.65e-05	0.00084	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—TNF—chronic obstructive pulmonary disease	2.65e-05	0.00084	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—EGFR—chronic obstructive pulmonary disease	2.63e-05	0.000834	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.58e-05	0.000818	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.58e-05	0.000816	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	2.57e-05	0.000813	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.52e-05	0.000797	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	2.5e-05	0.000792	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.48e-05	0.000786	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	2.45e-05	0.000777	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.45e-05	0.000776	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	2.44e-05	0.000773	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—MMP9—chronic obstructive pulmonary disease	2.42e-05	0.000767	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	2.42e-05	0.000766	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.41e-05	0.000765	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	2.36e-05	0.000748	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.32e-05	0.000735	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.31e-05	0.000731	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GCLC—chronic obstructive pulmonary disease	2.29e-05	0.000727	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.22e-05	0.000703	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.22e-05	0.000703	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—MMP1—chronic obstructive pulmonary disease	2.18e-05	0.000689	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	2.17e-05	0.000689	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.14e-05	0.000678	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.14e-05	0.000678	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—IL6—chronic obstructive pulmonary disease	2.14e-05	0.000678	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—IL6—chronic obstructive pulmonary disease	2.11e-05	0.000667	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—LEP—chronic obstructive pulmonary disease	2.11e-05	0.000667	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CTGF—chronic obstructive pulmonary disease	2.09e-05	0.000663	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.07e-05	0.000656	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GCLC—chronic obstructive pulmonary disease	2.05e-05	0.000648	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.04e-05	0.000647	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.02e-05	0.000638	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	2e-05	0.000632	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	1.99e-05	0.00063	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.96e-05	0.00062	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.95e-05	0.000618	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.93e-05	0.000611	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.91e-05	0.000605	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.88e-05	0.000596	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.88e-05	0.000595	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CTGF—chronic obstructive pulmonary disease	1.87e-05	0.000592	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.86e-05	0.00059	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.85e-05	0.000586	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.83e-05	0.000579	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.79e-05	0.000567	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.78e-05	0.000564	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	1.77e-05	0.000561	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.74e-05	0.000552	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.72e-05	0.000546	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.72e-05	0.000545	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.7e-05	0.00054	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.67e-05	0.000528	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.62e-05	0.000513	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.62e-05	0.000513	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	1.61e-05	0.00051	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.61e-05	0.00051	CbGpPWpGaD
Procainamide—ACHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.59e-05	0.000503	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	1.58e-05	0.000502	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	1.57e-05	0.000497	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.56e-05	0.000492	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.54e-05	0.000487	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.52e-05	0.00048	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	1.51e-05	0.00048	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.51e-05	0.000478	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.5e-05	0.000476	CbGpPWpGaD
Procainamide—ACHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.48e-05	0.000468	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	1.44e-05	0.000456	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.44e-05	0.000455	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.43e-05	0.000454	CbGpPWpGaD
Procainamide—BCHE—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.42e-05	0.000448	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.4e-05	0.000444	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CXCL8—chronic obstructive pulmonary disease	1.4e-05	0.000443	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	1.39e-05	0.000439	CbGpPWpGaD
Procainamide—BCHE—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.32e-05	0.000418	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.28e-05	0.000406	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.26e-05	0.0004	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	1.26e-05	0.000399	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.25e-05	0.000396	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ALB—chronic obstructive pulmonary disease	1.21e-05	0.000383	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.19e-05	0.000378	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	0.000373	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.18e-05	0.000373	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—NOS3—chronic obstructive pulmonary disease	1.16e-05	0.000367	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.12e-05	0.000354	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.11e-05	0.000351	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.000348	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.00033	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.03e-05	0.000326	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ALB—chronic obstructive pulmonary disease	9.53e-06	0.000302	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.52e-06	0.000302	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.51e-06	0.000301	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	9.41e-06	0.000298	CbGpPWpGaD
Procainamide—ACHE—Metabolism—NOS3—chronic obstructive pulmonary disease	9.11e-06	0.000289	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	8.59e-06	0.000272	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	8.56e-06	0.000271	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ALB—chronic obstructive pulmonary disease	8.5e-06	0.000269	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.5e-06	0.000269	CbGpPWpGaD
Procainamide—BCHE—Metabolism—NOS3—chronic obstructive pulmonary disease	8.13e-06	0.000258	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.91e-06	0.000251	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	7.77e-06	0.000246	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.72e-06	0.000245	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ALB—chronic obstructive pulmonary disease	7.59e-06	0.00024	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.43e-06	0.000235	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—NOS3—chronic obstructive pulmonary disease	7.26e-06	0.00023	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ALB—chronic obstructive pulmonary disease	7.08e-06	0.000224	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.91e-06	0.000219	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.77e-06	0.000214	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.6e-06	0.000209	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.51e-06	0.000206	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.07e-06	0.000192	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.75e-06	0.000182	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	5.68e-06	0.00018	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.42e-06	0.000172	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.18e-06	0.000164	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.59e-06	0.000145	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	4.37e-06	0.000138	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.15e-06	0.000132	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.91e-06	0.000124	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.74e-06	0.000118	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.73e-06	0.000118	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.42e-06	0.000108	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.36e-06	0.000106	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.82e-06	8.93e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.58e-06	8.17e-05	CbGpPWpGaD
